We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
12 hedge funds and large institutions have $305K invested in Atossa Therapeutics in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
20% more funds holding
Funds holding: 10 → 12 (+2)
7% more capital invested
Capital invested by funds: $285K → $305K (+$20K)
0.03% more ownership
Funds ownership: 0.03% → 0.06% (+0.03%)
Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$97.8K |
| 2 |
Renaissance Technologies
New York
|
+$66.6K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$40.3K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$26.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.3K |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$511 |